Recently Updated
- 12/15/2009
- Medical Abortion Guidebook
- 11/05/2009
- List of Mifepristone Approval
- 11/04/2009
- Map of Mifepristone Approval
- 05/25/2009
- Clinical Studies List
- 05/04/2009
- Medical Abortion Program Brief
Improving Current Therapies and Exploring New Options in Abortifacient Technology
The supreme court and the partial-birth abortion ban act of 2003
Abortion in the Middle East and North Africa
Abortion and sex determination
Community-based kangaroo mother care to prevent neonatal and infant mortality
Materials Development Activities Brief
Misoprostol for Early Abortion
Annotated Bibliography - Misoprostol for Early Abortion
Reference List - Misoprostol for Early Abortion
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Mifepristone medical abortion in Albania
Regimens of misoprostol with mifepristone for early medical abortion
Use of sequential serum hCG and sonography for medical abortion only when indicated
Are two doses of misoprostol after mifepristone for early abortion better than one?
Alternatives to mifepristone for early medical abortion
Mifepristone for late first trimester abortion
Can mifepristone medical abortion be simplified?
Methotrexate compared to misoprostol alone for early medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Medical Abortion Program Brief
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Supervision for use of mifepristone medical abortion
Integrating medical abortion into safe abortion services in South Africa
Expanding Choice in Abortion Services in Armenia
Two distinct oral routes of misoprostol in mifepristone medical abortion
Sublingual misoprostol after mifepristone
Non-physician clinicians can safely provide first trimester medical abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women’s choices in medical abortion in Turkey
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Home administration of misoprostol for early medical abortion in India
Annotated Bibliography - Mifepristone Medical Abortion
Alternatives to Routine Follow-Up for Early Medical Abortion
Misoprostol and Teratogenicity: Reviewing the Evidence
Route of Misoprostol Administration
Misoprostol for Women’s Health
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Comparison of serum markers for thrombophilia and autoimmune disease
Policy and Advocacy Activities Brief
Postpartum Hemorrhage: A Challenge for Safe Motherhood
Postpartum Hemorrhage: Responding to the Challenge
PPH Prevention Study in Pakistan
PPH Treatment Study in Pakistan
PPH Misoprostol Adjunct Treatment Study
Misoprostol PPH Treatment Study
Misoprostol for Prevention of Postpartum Hemorrhage
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Postpartum Hemorrhage Program Brief
Treatment of postpartum hemorrhage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Blood Loss After Vaginal Delivery
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Fever after treatment of postpartum hemorrhage
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1 of 2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2 of 2
Misoprostol: A New Addition to Post Abortion Care
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Misoprostol for Incomplete Abortion and Miscarriage
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Tanzania
Misoprostol for incomplete abortion in Burkina Faso
Treatment of incomplete abortion and miscarriage with misoprostol
Misoprostol to treat missed abortion in the first trimester
Pregnancy Failure and Miscarriage Program Brief
Sublingual misoprostol for incomplete abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Social Science Research Activities Brief
Relationship of Hormonal Contraception to HIV
FAQs on Fatal Infection and Medical Abortion - Summary
Outlook Newsletter on Hormonal Contraception and HIV
Issue Brief on Hormonal Contraception and HIV
FAQ on Hormonal Contraception and HIV
FAQs on Fatal Infection and Medical Abortion - Technical Version
Clostridium sordellii infection in medical abortion
Reproductive intentions among HIV-positive women and men
Perspectives on reproductive decision-making amongst HIV-infected individuals
STIs/ HIV/ Infectious Disease Program Brief
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Technical Assistance Activities Brief